101 related articles for article (PubMed ID: 1638777)
1. Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V.
Biesenbach G; Zazgornik J
Clin Nephrol; 1992 Jun; 37(6):274-9. PubMed ID: 1638777
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.
Hunninghake DB; Stein EA; Dujovne CA; Harris WS; Feldman EB; Miller VT; Tobert JA; Laskarzewski PM; Quiter E; Held J
N Engl J Med; 1993 Apr; 328(17):1213-9. PubMed ID: 8464431
[TBL] [Abstract][Full Text] [Related]
3. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
[TBL] [Abstract][Full Text] [Related]
4. [Lovastatin: short-term treatment of hypercholesterolemia; multicenter clinical trial].
Brusco OJ
Medicina (B Aires); 1990; 50(1):69-73. PubMed ID: 2292916
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
[TBL] [Abstract][Full Text] [Related]
7. [Lowering of the plasma lipid concentration with lovastatin. A clinical study in patients with primary hypercholesterolemia].
Grüneberger S; Dreyer M; Kangah R; Reinicke A; Staisch C; Steinhagen-Thiessen E; Müller P; Simon B; Dammann HG
Dtsch Med Wochenschr; 1989 Nov; 114(45):1734-9. PubMed ID: 2806106
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ
Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
10. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
12. [Lovastatin in the treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus patients].
Zanella MT; Plavinik F; Zampieri M; Peres RB; Ribeiro AB
Arq Bras Cardiol; 1993 Jul; 61(1):27-31. PubMed ID: 8285861
[TBL] [Abstract][Full Text] [Related]
13. [Lovastatin efficacy and tolerance in primary hypercholesterolemia. The German Lovastatin Study Group].
Thiery J; Basten A; Sommerburg C; Seidel D
Dtsch Med Wochenschr; 1991 Jun; 116(23):887-94. PubMed ID: 2040207
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin in the treatment of hypercholesterolemia in elderly patients.
Antonicelli R; Onorato G; Pagelli P; Pierazzoli L; Paciaroni E
Clin Ther; 1990; 12(2):165-71. PubMed ID: 2354486
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
Crespo N; Illnait J; Más R; Fernández L; Fernández J; Castaño G
Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
[TBL] [Abstract][Full Text] [Related]
16. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
19. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
Sánchez Domínguez J; Rodríguez Padial L; Navarro A; Barcina C; Fernández E; Rivera G; Cuesta L; Lázaro-Carrasco E
Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
Denke MA; Grundy SM
Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
